ivacaftor

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Vertex Pharmaceuticals Incorporated

Overview

ivacaftor is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 13 tracked IPF clinical trials.

ivacaftor clinical trials

NCT02445053 (Not specified)NCT00953706 (Phase 2)NCT01614457 (Phase 3)NCT01705145 (Phase 3)NCT02934698 (Phase 3)NCT03068312 (Phase 3)NCT02742519 (Phase 3)NCT01614470 (Phase 3)NCT02412111 (Phase 3)NCT03475381 (Not specified)NCT01262352 (Phase 2)NCT01685801 (Phase 2)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about ivacaftor for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.